Will a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
One-OffHealth & MedicineBusiness & Corporate2moManifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastNo 83.9%
Forecasters
11
Question type
binary
Methodology
Play-money forecasting platform
Source type
Forecast
Market data
Updated 48 minutes ago
LaggingFeb 11, 25, 9:51 PM UTCJan 1, 27, 4:59 AM UTC
Trends
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
Manifold MarketsWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWill a top 5 US fast-food chain launch a non-dairy milkshake nationally by end of 2027?
Manifold MarketsWill an American national fast food chain use lab-grown/cultured meat in a product by 2030?
Manifold MarketsWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
KalshiWill Johnson & Johnson (JNJ) Q3 MedTech revenue be above __?
PolymarketRules
Must be by market close (end of 2026)
- For background:
- https://www.nytimes.com/2024/11/19/magazine/ozempic-junk-food.html
- Or this tweet:
- https://x.com/ChristosArgyrop/status/1889163083123175583
- Resolves YES if there is evidence that a junk food or fast food company (I will apply this label very generously and broadly in edge cases) has used some sort of engineered additive specifically to mitigate the effects of GLP-1 agonists like Ozempic.